Aging does not impact safety and efficacy of biologic or targeted synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis by Yasemin Tombak, Ajda Bal, Emel Eksioglu, Nihan Abidin, Ozgur Zeliha Karaahmet, Deniz Dulgeroglu

Subjects: “…bDMARDs…”
Get full text

Central sensitization reduces the satisfaction of patients with rheumatoid arthritis. The data of prospective study by A. S. Potapova, A. E. Karateev, E. Yu. Polishchuk, P. A. Sholkina, E. S. Filatova, V. N. Amirjanova, A. M. Lila

Subjects: Get full text

Improvement in rheumatoid sarcopenia with biological therapy; muscle ultrasound study by Zehra Özsoy, Merve Hafızoğlu, Zeynep Öztürk, Zeynep Şahiner, Didem Karaduman, Güllü Sandal Uzun, Erdinç Ünaldı, Yağmur Tahıllıoğlu, Meltem Gülhan Halil

Subjects: Get full text

QuantiFERON-TB Gold Plus for screening and monitoring latent tuberculosis infection in spondyloarthritis patients by Zehra Ozsoy, Adem Ozdemir, Mustafa Ekici, Emre Bilgin, Asena Eken, Zeynep Saribas, Ahmet C Inkaya, Deniz Koksal, Burcin Sener, Ihsan Ertenli, Omer Karadag, Levent Kilic

Subjects: Get full text

Tuberculosis infection in patients with rheumatic diseases under different treatments by Tianhui Liu, Hongxuan Yan, Mengqiu Gao

Subjects: “…bDMARDs…”
Get full text

Unstable psoriasis in the setting of psoriatic arthritis: A rare presentation by Roma Raj, Abir Saraswat, Koshy Nithin Thomas, Latika Gupta

Subjects: “…dmards…”
Get full text

Perioperative management with DMARDs in rheumatic diseases: a scoping review of clinical guidelines by Alice Terrett, Athena Chin, Mihye Kwon, Samuel Whittle, Catherine Hill

Subjects: Get full text

Treating rheumatoid arthritis in Zanzibar: a cost effectiveness study comparing conventional, biologic, and targeted-synthetic disease modifying anti-rheumatic drugs by Sanaa S. Said, Sanaa S. Said, Sanaa S. Said, Sanaa S. Said, Sanaa S. Said, Melf-Jakob Kühl, Melf-Jakob Kühl, Bjorg-Tilde Svanes Fevang, Bjorg-Tilde Svanes Fevang, Tone Wikene Nystad, Kjell Arne Johansson, Kjell Arne Johansson

Subjects: Get full text

Where Do We Stand in the Management of Rheumatoid Arthritis Ahead of EULAR/ACR 2025? by Adriana Liliana Vlad, Corina Popazu, Alina-Maria Lescai, Doina Carina Voinescu, Alexia Anastasia Ștefania Baltă

Subjects: Get full text

Osteoclast development from peripheral blood monocytes is reduced in patients with radiographic axial spondyloarthritis on biological therapy by Cecilia Engdahl, Malin C. Erlandsson, Magnus Hallström, Anna Deminger, Helena Forsblad-d’Elia

Subjects: Get full text

Risk of serious bacterial infections in inflammatory rheumatic or bowel disease patients during biological therapies: nationwide Danish cohort study by Emma Cathrine Højberg Platz, Gustav Emil Laugesen, Anne Ahrens Østergaard, Keld-Erik Byg, Inge Petersen, Isik Somuncu Johansen

Subjects: “…bDMARDs…”
Get full text

Coronavirus Disease 2019 (COVID-19) and Immune-mediated Rheumatic Diseases. Recommendations of the Association of Rheumatologists of Russia by E. L. Nasonov, A. M. Lila, V. I. Mazurov, B. S. Belov, A. E. Karateev, T. V. Dubinina, O. A. Nikitinskaya, A. A. Baranov, D. I. Abdulganieva, S. V. Moiseev, A. I. Zagrebneva

Subjects: Get full text

Small molecules in idiopathic inflammatory myopathies: a systematic review and a multicenter case series about Janus kinase inhibitors and apremilast by Chiara Rizzo, Silvia Grazzini, Edoardo Conticini, Hector Chinoy, Roberto D’Alessandro, Federica Camarda, Luca Cantarini, Bruno Frediani, Giuliana Guggino, Lidia La Barbera

Subjects: Get full text

The use of methotrexate in rheumatoid arthritis. Recommendations of the All-Russian public organization “Association of Rheumatologists of Russia” by E. L. Nasonov, V. N. Amirjanova, Y. A. Olyunin, Y. V. Muravyev, A. A. Baranov, E. V. Zonova, E. N. Otteva, A. I. Zagrebneva, D. I. Abdulganieva, P. I. Pchelnikova

Subjects: Get full text

Outcomes of children with juvenile idiopathic arthritis receiving biological disease-modifying anti-rheumatic drugs: a retrospective single-centre experience from IndiaResearch in... by Pavneet Kaur, Farheen Kizhakkeveettil Saheer, Bala Siva Rama Krishna J, Banoth Sreeshanth, Ayisha Kavil Peedika, Bareddy Sai Thrisha Reddy, Ashish Datt Upadhyay, Rakesh Lodha, Sushil Kumar Kabra, Narendra Bagri

Subjects: Get full text

Patient access to reimbursed biological disease-modifying antirheumatic drugs in the European region by Zoltán Kaló, Zoltán Vokó, Andrew Östör, Emma Clifton-Brown, Radu Vasilescu, Alysia Battersby, Edward Gibson

Subjects: “…Biological disease-modifying antirheumatic drugs (bDMARDs)…”
Get full text

Incidence and reasons for biologic and targeted synthetic DMARD switching in juvenile idiopathic arthritis: a real- life stratified analysis by Daniel Clemente, Leticia Leon, Juan Carlos Nieto-Gonzalez, Alina Lucica Boteanu, Laura Trives Folguera, Antía Asunción García-Fernández, Helena Amar Muñoz, Aliuska Palomeque, Juan Carlos López Robledillo, Lydia Abasolo

Subjects: “…Biologic and targeted synthetic DMARDs…”
Get full text

Difficult-to-treat psoriatic arthritis: refining the definition using a statistical model in a real-life cohort by Ennio Giulio Favalli, Ennio Giulio Favalli, Giacomo Biganzoli, Gilberto Cincinelli, Gilberto Cincinelli, Matteo Ferrito, Matteo Ferrito, Ester Luconi, Maria Manara, Martina Biggioggero, Patrizia Boracchi, Patrizia Boracchi, Roberto Caporali, Roberto Caporali

Subjects: Get full text

Targeting rheumatoid arthritis: a molecular perspective on biologic therapies and clinical progress by Ankit Jain, Mamta Bishnoi, Shiv Kumar Prajapati, Sweta Acharya, Sumedha Kapre, Gautam Singhvi, Srinath Palakurthi

Subjects: Get full text

Mitochondria as a Disease-Relevant Organelle in Rheumatoid Arthritis: A Key Breakout in Fight Against the Disease by Antonella Iaconis, Francesco Molinari, Roberta Fusco, Rosanna Di Paola

Subjects: Get full text